Programmed cell death protein 1 is a marker for neoadjuvant chemotherapy response in triple-negative breast cancer
{{output}}
Objective: Tumor-infiltrating lymphocytes are detectable in up to 75% of triple-negative breast cancer. The composition of these infiltrates may influence prognosis and is not known regarding regulatory or effector lymphocytes. T... ...
